Just as I have just mentioned, almost all of our customers have passed the exam as well as getting the related certification easily with the help of our CCDM exam torrent, we strongly believe that it is impossible for you to be the exception. So choosing our Certified Clinical Data Manager exam question actually means that you will have more opportunities to get promotion in the near future, at the same time, needless to say that you will get a raise in pay accompanied with the promotion. What’s more, when you have shown your talent with Certified Clinical Data Manager certification in relating field, naturally, you will have the chance to enlarge your friends circle with a lot of distinguished persons who may influence you career life profoundly. So why are you still hesitating for purchasing our CCDM Guide Torrent? Your bright future is starting from here!
| Topic | Details |
|---|---|
| Topic 1 |
|
| Topic 2 |
|
| Topic 3 |
|
| Topic 4 |
|
| Topic 5 |
|
We own three versions of the CCDM exam torrent for you to choose. They conclude PDF version, PC version and APP online version. You can choose the most convenient version of the CCDM quiz torrent. The three versions of the CCDM test prep boost different strengths and you can find the most appropriate choice. For example, the PDF version is convenient for download and printing and is easy and convenient for review and learning. It can be printed into papers and is convenient to make notes. You can learn the CCDM Test Prep at any time or place and repeatedly practice. The version has no limit for the amount of the persons and times. The PC version of CCDM quiz torrent is suitable for the computer with Windows system. It can simulate real operation exam atmosphere and simulate exams.
NEW QUESTION # 52
Which of the following data verification checks would most likely be included in a manual or visual data review step?
Answer: B
Explanation:
Manual or visual data review is used to identify complex clinical relationships and contextual inconsistencies that cannot be detected by automated edit checks.
According to the GCDMP (Chapter: Data Validation and Cleaning), automated edit checks are ideal for structured validations, such as missing fields (option C), reference ranges (option D), or predefined value lists (option A). However, certain clinical cross-checks-such as verifying adverse event treatments against concomitant medication records-require clinical judgment and contextual understanding.
For example, if an adverse event of "severe headache" was reported but no analgesic appears in the concomitant medication log, the data may warrant manual review and query generation. These context-based checks are best performed by trained data reviewers or medical data managers during manual data review cycles.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Validation and Cleaning, Section 6.3 - Manual Review and Clinical Data Consistency Checks ICH E6 (R2) Good Clinical Practice, Section 5.18.4 - Clinical Data Review Responsibilities FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations - Data Verification Principles
NEW QUESTION # 53
In the transfer of obligations for a double-blind, multi-center trial, a sponsor has maintained the task of creating the randomization schedule. Who at the sponsor company should create the randomization schedule?
Answer: D
Explanation:
In a double-blind clinical trial, the randomization schedule must be generated by an independent biostatistician not directly involved in study operations or data management to preserve study blinding and integrity.
According to ICH E9 and the GCDMP (Chapter: Regulatory Requirements and Compliance), randomization generation and blinding must be handled in a way that prevents bias or unintentional unblinding of study personnel. The sponsor's biostatistician not assigned to the project (Option C) is the appropriate person because they have the necessary statistical expertise but remain operationally independent from study execution.
A project biostatistician (Option D) or programmer (Option A) directly involved in data analysis could inadvertently compromise blinding. The CRO biostatistician (Option B) should not perform this function if the sponsor retains randomization responsibility.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Regulatory Requirements and Compliance, Section 6.4 - Randomization and Blinding ICH E9 - Statistical Principles for Clinical Trials, Section 5.4 - Randomization Procedures and Blinding FDA Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics, Section 4.3 - Maintaining Blinding Integrity
NEW QUESTION # 54
All of the following are preparation processes the data manager needs to take prior to database closure EXCEPT:
Answer: C
Explanation:
Before database lock, the Data Manager must confirm that all collected data are complete, validated, and reconciled across systems. This includes:
Ensuring data completeness (B) - confirming all expected forms and data files have been received.
Verifying coded data (A) - ensuring no pending terms remain in coding dictionaries like MedDRA or WHO Drug.
Performing SAE reconciliation (C) - cross-checking the clinical database against the safety system for accuracy.
However, ensuring study close-out visits (D) is not a data management function; it falls under clinical operations and monitoring responsibilities. While data management may review confirmation of site close-outs, the activity itself is not part of pre-database lock procedures.
Therefore, option D correctly identifies the exception-an activity outside the data manager's direct scope of responsibility before database closure.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Database Lock and Archiving, Section 5.3 - Pre-Lock Validation and Reconciliation Activities ICH E6(R2) GCP, Section 5.5.3 - Data Handling and Quality Control Prior to Lock FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6.1 - Database Management and Lock Procedures
NEW QUESTION # 55
A study takes body-composition measurements at baseline using a DEXA scanner. Which information is needed to correctly associate the body-composition data to the rest of the study data?
Answer: B
Explanation:
To properly associate body-composition data (from a DEXA scanner) with other study data, both the subject number and the visit number are required.
According to the GCDMP (Chapter: Data Management Planning and Study Start-up), every clinical data record must be uniquely identifiable and linkable to a specific subject and study event. The subject number identifies the participant, while the visit number defines the temporal context in which the measurement was taken.
Without both identifiers, data integration becomes ambiguous-especially if multiple assessments occur over time (e.g., baseline, week 12, end of study). Including both ensures data traceability, integrity, and alignment with the protocol-defined schedule of events.
Study number (option A) alone does not distinguish between visits or subjects, and visit number alone (option C) lacks linkage to the individual participant.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Management Planning and Study Start-up, Section 4.4 - Data Linking and Identification Requirements ICH E6 (R2) GCP, Section 5.5.3 - Data Traceability Principles FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations - Data Identification Requirements
NEW QUESTION # 56
A study is collecting pain levels three times a day. Which is the best way to collect the data?
Answer: A
Explanation:
The optimal method for collecting frequent patient-reported pain data is through electronic Patient-Reported Outcomes (ePRO) with built-in reminder functionality.
According to the GCDMP (Chapter: Electronic Data Capture Systems), ePRO systems provide a validated, real-time, and user-friendly interface for subjects to record time-sensitive data accurately. The use of automated reminders ensures compliance with protocol-specified data collection times, improving data completeness and accuracy.
Paper diaries (option A) are prone to recall bias and backfilling, while daily site calls (option B) are resource-intensive and introduce human error. IVRS systems (option C) are acceptable but less efficient and user-friendly than modern ePRO applications, which can integrate timestamp validation, compliance monitoring, and real-time alerts.
ePRO systems also comply with FDA 21 CFR Part 11 and ICH E6 (R2) for audit trails, authentication, and validation, making them the preferred solution for repeated PRO data collection.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Electronic Data Capture (EDC) Systems, Section 6.1 - Use of ePRO for Repeated Measures FDA Guidance for Industry: Electronic Source Data in Clinical Investigations, Section 5 - ePRO Compliance and Validation ICH E6 (R2) GCP, Section 5.5.3 - Electronic Data Systems and Recordkeeping
NEW QUESTION # 57
......
You can also set the number of SCDM CCDM dumps questions to attempt in the practice test and time as well. The web-based SCDM CCDM practice test software needs an active internet connection and can be accessed through all major browsers like Chrome, Edge, Firefox, Opera, and Safari. Our Desktop-based SCDM CCDM Practice Exam Software is very suitable for those who don't have an internet connection. You can download and install it within a few minutes on Windows-based PCs only and start preparing for the Certified Clinical Data Manager exam.
New CCDM Exam Format: https://www.prep4sureguide.com/CCDM-prep4sure-exam-guide.html
